IP Library Granted Patent US 11,090,369
Granted Patent B2
US 11,090,369 · App. 16/314,168 · Granted Aug 17, 2021

Antimicrobial compositions and methods employing same

Inventor: Matthew F. Myntti (St. Augustine, FL)
Assignee: Next Science IP Holdings Pty Ltd
A61K38/47A01N37/02A01N63/00A61K9/0043A61K9/0046A61K9/08A61K47/10A61K47/12A61K47/20A61P31/04C12Y302/01017
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,090,369
App. No.
16/314,168
Granted
Aug 17, 2021
Kind
B2
Abstract

A composition that can be used to treat a wide spectrum of gram positive and gram negative bacteria, including but not limited to those in biofilm form, and other microbes can be used in cilia-containing areas such as the sinus cavities and middle/inner ear, while resulting in no, or very minimal amounts of, deciliation. Where such a targeted treatment area includes a biofilm, the composition often can detach and assist in removing the biofilm from affected tissue. Many embodiments of the composition are biocompatible.

Claims (26)

1. An antimicrobial composition suitable for introduction into cilia-containing areas of an animal body, said composition consisting essentially of:

a) a solvent component that consists of water and at least 2% (w/v) of an organic solvent selected from ethanol and DMSO, and

b) a solute component that consists of an organic polyacid, a salt of an organic polyacid, no more than 1% (w/v) of one or more anionic surfactants and at least 0.005% (w/v) of lysozyme,

said composition having a pH of from 6 to 8 and an effective solute concentration of no more than 250 mOsm/L.

2. The composition of claim 1 wherein said composition has an effective solute concentration of no more than 200 mOsm/L.

3. The composition of claim 1 wherein said organic polyacid is citric acid.

4. The composition of claim 1 wherein said salt of an organic polyacid is a sodium salt of citric acid.

5. The composition of claim 1 wherein said solute component includes no more than 0.8% (w/v) of said one or more anionic surfactants.

6. The composition of claim 5 wherein said solute component includes no more than 0.7% (w/v) of said one or more anionic surfactants.

7. The composition of claim 6 wherein said solute component includes no more than 0.5% (w/v) of said one or more anionic surfactants.

8. The composition of claim 7 wherein said solute component is free of anionic surfactants.

9. The composition of claim 1 wherein said organic solvent is DMSO.

10. The composition of claim 1 wherein said organic solvent is ethanol.

11. An antimicrobial composition suitable for introduction into cilia-containing areas of an animal body, said composition consisting of:

a) a solvent component that consists of water and at least 2% (w/v) of an organic solvent selected from ethanol and DMSO, and

b) a solute component that consists of an organic polyacid, a salt of an organic polyacid, no more than 1% (w/v) of one or more anionic surfactants and at least 0.005% (w/v) of lysozyme,

said composition having a pH of from 6 to 8 and an effective solute concentration of no more than 250 mOsm/L.

12. The composition of claim 11 wherein said composition has an effective solute concentration of no more than 200 mOsm/L.

13. The composition of claim 11 wherein said organic polyacid is citric acid.

14. The composition of claim 11 wherein said salt of an organic polyacid is a sodium salt of citric acid.

15. The composition of claim 11 wherein said solute component includes no more than 0.8% (w/v) of said one or more anionic surfactants.

16. The composition of claim 15 wherein said solute component includes no more than 0.8% (w/v) of said one or more anionic surfactants.

17. The composition of claim 16 wherein said solute component includes no more than 0.8% (w/v) of said one or more anionic surfactants.

18. The composition of claim 17 wherein said solute component is free of anionic surfactants.

19. The composition of claim 11 wherein said organic solvent is DMSO.

20. The composition of claim 11 wherein said organic solvent is ethanol.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2025
From: NEXT SCIENCE IP HOLDINGS PTY LTD
To: OSARTIS GMBH
Reel/Frame 072590/0763 →
Continuity (3)
Provisional Application 62524522 · Jun 24, 2017
Provisional Application 62357147 · Jun 30, 2016
Related Publication 20190262433A1 · Aug 29, 2019
Cited By (1)
US 12,419,830